🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 17 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
30/05/2007 65,80 72,90 64,55 71,90 +8,12% 12,69% 56.810
29/05/2007 64,80 66,50 63,00 66,50 +2,62% 5,40% 10.710
25/05/2007 64,50 66,80 63,00 64,80 +0,31% 5,89% 14.550
24/05/2007 66,90 67,30 64,50 64,60 -3,29% 4,19% 15.370
23/05/2007 70,00 70,00 66,70 66,80 -4,84% 4,71% 25.980
22/05/2007 70,50 72,50 69,30 70,20 -0,85% 4,54% 15.040
21/05/2007 70,30 72,00 68,20 70,80 +1,14% 5,41% 24.470
18/05/2007 65,90 70,00 63,60 70,00 +6,22% 9,71% 35.820
17/05/2007 64,50 66,00 62,80 65,90 +2,65% 4,96% 19.700
16/05/2007 61,90 65,60 61,90 64,20 +4,73% 5,98% 19.920
15/05/2007 64,00 64,00 60,80 61,30 -4,07% 5,00% 12.620
14/05/2007 68,10 69,00 62,50 63,90 -6,03% 9,54% 21.170
11/05/2007 61,61 68,50 59,30 68,00 +11,29% 14,93% 26.400
10/05/2007 67,50 68,30 61,10 61,10 -10,15% 10,67% 31.780
09/05/2007 69,00 69,30 67,30 68,00 -2,16% 2,90% 15.340
08/05/2007 71,10 71,80 69,00 69,50 -2,80% 3,94% 17.710
07/05/2007 70,00 71,50 67,80 71,50 +3,77% 5,29% 42.980
04/05/2007 66,10 69,50 65,00 68,90 +5,35% 6,81% 33.460
03/05/2007 65,00 65,50 63,20 65,40 +2,35% 3,54% 12.430
02/05/2007 64,00 65,50 63,30 63,90 -0,16% 3,44% 15.170
01/05/2007 63,50 65,50 63,30 64,00 -0,62% 3,46% 12.720
30/04/2007 63,40 65,50 62,00 64,40 +1,10% 5,52% 29.890
27/04/2007 61,10 64,10 60,20 63,70 +4,26% 6,38% 23.160
26/04/2007 63,10 65,00 60,00 61,10 -3,63% 7,92% 30.140
25/04/2007 61,40 66,50 61,20 63,40 +3,09% 8,63% 46.630
24/04/2007 57,10 63,49 56,60 61,50 +6,40% 12,07% 54.080
23/04/2007 59,00 59,50 56,00 57,80 -3,67% 5,93% 26.480
20/04/2007 53,50 60,00 51,00 60,00 +14,29% 16,82% 470.030
19/04/2007 54,60 54,70 52,50 52,50 -4,20% 4,03% 10.910
18/04/2007 52,80 55,40 52,10 54,80 +3,98% 6,25% 13.900